NORTHWEST BIOTHERAPEUTICS, INC

Inactive Instrument

Insiders Northwest Biotherapeutics, Inc OTC Bulletin Board

Equities

US66737P5017

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

06-29	Transcript : Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call
05-10	Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors	03-21	CI
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors	03-14	CI
Northwest Biotherapeutics Appoints Linda Liau to its Scientific Advisory Board	23-09-12	CI
Northwest Biotherapeutics, Inc. Announces Management Changes	20-06-08	CI
Northwest Biotherapeutics, Inc. Appoints Jean M. Davis as Chief Financial Officer, Chief Accounting Officer and Interim Chief Information Officer	19-12-13	CI
Northwest Biotherapeutics, Inc. Appoints David Innes as Vice President, Investor Relations	19-02-26	CI
Northwest Biotherapeutics Appoints Susan Bayh and Ambassador Cofer Black as Independent Directors	16-01-25	CI
Northwest Biotherapeutics Rejects Board Nomination by Woodford Investment	15-12-14	CI
Woodford Investment Seeks Appointment of Independent Non Executive Member to Board of Northwest Biotherapeutics	15-11-24	CI
Northwest Biotherapeutics, Inc. Names to Two Russell Indexes	14-06-16	CI
Northwest Biotherapeutics, Inc. Announces Board Appointments	12-04-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer